In this article, we will discuss the 10 Small-Cap Stocks That Are On Fire Right Now.
On April 22, Bipan Rai, Head of ETF strategy at BMO Global Asset Management, joined BNN Bloomberg to discuss the transition of the global economy into a stagflation-like regime in Q2 2026. He explained that while the previous period focused on easing monetary policy to boost growth, the current backdrop is defined by upside risks to inflation and observable downside risks to growth. Rai expressed significant concern about stagflation because it increases the correlation between equities and fixed income, removing the traditional diversification benefit, or ballast, that bonds typically provide in a portfolio. He emphasized that BMO is closely monitoring this shift, as a scenario where both asset classes return negative results is particularly problematic for money managers and individual investors alike.
Regarding corporate performance, Rai noted that earnings have remained resilient, with roughly an 82% beat rate so far. This resiliency has helped alleviate some concerns about high market valuations that persisted at the beginning of the year. However, he warned of a time component regarding geopolitical tensions in the Middle East. He explained that the longer the Strait of Hormuz remains closed or traffic is curtailed, the more it will weigh on forward-looking growth expectations. This situation, compounded by rising trade barriers and shifting long-term fundamentals, suggested that inflation risks remain skewed to the upside, which could negatively impact consumption, a critical growth variable for both the US and Canadian economies.
Our Methodology
We used screeners to identify stocks that are trading between $2 billion and $10 billion, and have exhibited strong year-to-date share price performance (at least 95%), and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Note: All data was sourced on April 27.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10 Small-Cap Stocks That Are On Fire Right Now
10. Cohu Inc. (NASDAQ:COHU)
Year-to-Date Performance: 95.57%
Cohu Inc. (NASDAQ:COHU) is one of the small-cap stocks that are on fire right now. On April 2, Cohu secured $30 million in follow-on orders from two customers for its Eclipse test platform, specifically configured with active thermal control. These orders are intended to support the production of next-gen HPC processors, which face increasingly complex power densities and thermal constraints. The equipment is scheduled for delivery over the next few quarters, reinforcing the company’s expanding footprint in the high-growth HPC sector as manufacturers prioritize thermally precise test architectures.
As part of these orders, one customer has subscribed to Cohu’s PAICe Prescriptive software analytics, a service projected to generate $330,000 in annual subscription fees. This AI-driven software will be deployed at an outsourced semiconductor assembly and test/OSAT partner to enhance overall equipment efficiency/OEE. By analyzing real-time signals and behavior patterns, the platform predicts potential hardware issues before they disrupt production, providing guided repair recommendations that significantly reduce troubleshooting time and the mean time to repair/MTTR.
Cohu Inc. President and CEO Luis Müller highlighted the strong momentum for the Eclipse platform, noting that additional customers are currently qualifying the system for their own processor testing needs. Due to this sustained demand, the company now expects its 2026 HPC segment revenue to reach the higher end of its $60 million to $85 million guidance. This growth underscores Cohu’s role in providing scalable, high-performance solutions essential for the evolving semiconductor manufacturing landscape.
Cohu Inc. is a California-based provider of semiconductor test equipment and services. It also provides AI process control and analytics-based monitoring software.
9. USA Rare Earth Inc. (NASDAQ:USAR)
Year-to-Date Performance: 96.30%
USA Rare Earth Inc. (NASDAQ:USAR) is one of the small-cap stocks that are on fire right now. On April 21, USA Rare Earth entered into a definitive agreement to acquire the Serra Verde Group for ~$2.8 billion to secure a diversified global supply chain for critical minerals. The transaction consists of $300 million in cash and the issuance of over 126 million new USA Rare Earth shares. Expected to close by Q3 2026, the acquisition includes the Pela Ema mine and processing facility in Goiás, Brazil, which is a rare large-scale producer of magnetic and heavy rare earths such as dysprosium, terbium, and yttrium.
The Serra Verde operation, which commenced production in 2024 following a $1.1 billion investment, is backed by $565 million in financing from the US International Development Finance Corporation. To further de-risk the project, the company has secured a 15-year offtake agreement with a special purpose vehicle funded by the US government and private sources. This agreement includes price floor guarantees for essential elements like neodymium and praseodymium, ensuring long-term stability for the production of high-performance NdFeB magnets.
By the end of 2027, the facility is projected to reach its phase-one capacity of 6,400 tonnes per annum of total rare earth oxides, generating an estimated annual EBITDA of $550 to $650 million. This acquisition complements USA Rare Earth Inc.’s (NASDAQ:USAR) existing capabilities, including its recent commercial production of high-purity yttrium in the UK.
USA Rare Earth Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements, currently developing a vertically integrated, domestic supply chain for rare earth element magnet production.
8. Power Integrations Inc. (NASDAQ:POWI)
Year-to-Date Performance: 98.35%
Power Integrations Inc. (NASDAQ:POWI) is one of the small-cap stocks that are on fire right now. On March 23, Power Integrations introduced the TOPSwitchGaN flyback IC family, a breakthrough that extends the power range of flyback converters to 440 W. This innovation allows engineers to use a much simpler flyback architecture for high-power applications that previously required complex resonant and LLC topologies.
By combining the company’s PowiGaN technology with its established TOPSwitch architecture, the new ICs significantly reduce system cost, complexity, and design time while improving overall manufacturability. The new ICs achieve 92% efficiency across the entire load range and consume less than 50 mW in standby mode, exceeding European Energy-related Products/ErP regulations.
The use of 800 V PowiGaN switches enables low conduction and switching losses, allowing for operation at frequencies up to 150 kHz, which helps minimize transformer size. These benefits make the family ideal for demanding applications such as high-end appliances, industrial power supplies, and e-bike chargers. Power Integrations Inc. offers the TOPSwitchGaN ICs in two distinct packages: the low-profile eSOP-12 for ultra-slim, heat-sink-free designs up to 135 W, and the eSIP-7 for higher power outputs when paired with a simple clip-on heat sink.
Power Integrations Inc. provides analog and mixed-signal semiconductor solutions to original equipment manufacturers and distributors.
7. Cardinal Infrastructure Group (NASDAQ:CDNL)
Year-to-Date Performance: 102.34%
Cardinal Infrastructure Group (NASDAQ:CDNL) is one of the small-cap stocks that are on fire right now. On April 9, Cardinal Infrastructure secured a $24 million contract for the initial phase of a large-scale, multi-phase data center campus development. This project marks the first mission-critical data center award in the company’s history, signaling a move into high-growth technology infrastructure. Work is scheduled to commence in Q2 2026, with substantial completion targeted for 2027.
Under the terms of the agreement, Cardinal Infrastructure will self-perform the entire civil infrastructure scope for the site. Responsibilities include earthwork, erosion and sediment control, wet utilities installation, and stormwater management, as well as final paving and surface improvements. The contract highlights the company’s ability to meet the rigorous technical standards and aggressive timelines required by major technology clients.
CEO Jeremy Spivey noted that this award is a key milestone in Cardinal Infrastructure’s broader growth strategy to diversify its end markets. By expanding into the technology sector, the company aims to use its large-scale site work expertise to deliver long-term value for shareholders. This pivot into complex data center infrastructure positions Cardinal Infrastructure Group to compete for more sophisticated projects within the digital economy.
Cardinal Infrastructure Group is a full-service civil contracting firm providing site development and utility services across the southeastern US. The company specializes in grading, paving, and water/sewer installations for residential, commercial, and municipal projects.
6. Spyre Therapeutics Inc. (NASDAQ:SYRE)
Year-to-Date Performance: 118.53%
Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the small-cap stocks that are on fire right now. On April 16, Spyre Therapeutics successfully closed an underwritten public offering, generating ~$463.5 million in gross proceeds. The final total reflects the full exercise of the underwriters’ option to purchase an additional 975,000 shares, bringing the total number of shares of common stock sold to 7,475,000 at a public offering price of $62.00 per share.
The company plans to use these funds to further its development of long-acting antibodies and combination therapies targeting inflammatory bowel disease/IBD and rheumatic conditions. The offering was managed by a consortium of major financial institutions, with Jefferies LLC, Goldman Sachs & Co. LLC, Evercore ISI, and Guggenheim Securities acting as joint book-running managers. LifeSci Capital LLC served as a passive bookrunner.
The transaction was conducted under a registration statement that became effective in February, with the final prospectus supplement filed concurrently with the closing. This substantial capital infusion strengthens Spyre Therapeutics Inc.’s (NASDAQ:SYRE) financial position as it seeks to redefine standards of care for chronic inflammatory diseases.
Spyre Therapeutics Inc. is a US biotechnology company focused on developing medicines for people living with inflammatory bowel disease and rheumatic diseases. It develops advanced antibodies engineered for prolonged activity and formulated for delivery as monotherapies.
5. Oruka Therapeutics (NASDAQ:ORKA)
Year-to-Date Performance: 149.38%
Oruka Therapeutics (NASDAQ:ORKA) is one of the small-cap stocks that are on fire right now. On April 27, Oruka Therapeutics announced positive interim results from its EVERLAST-A Phase 2a trial for ORKA-001, a long-acting monoclonal antibody targeting moderate-to-severe plaque psoriasis. The study met its primary endpoint, with 63.5% of patients achieving complete skin clearance (PASI 100) by Week 16. These efficacy rates are numerically higher than those of other current IL-23p19 inhibitors, placing ORKA-001 among the top-performing treatments for this condition.
The safety profile for ORKA-001 remained favorable and consistent with its drug class, with no serious treatment-emergent adverse events reported in the treated group. Most side effects were mild, with upper respiratory tract infections being the only common event observed. Crucially, updated data from earlier phases suggest the drug maintains effective concentrations for an entire year after a single dose, reinforcing the potential for once-yearly dosing, an improvement over current treatment frequencies.
Following these results, Oruka Therapeutics plans to release longer-term follow-up data, including 52-week results for a subset of patients, in H2 2026. The company is also moving forward with its EVERLAST-B Phase 2b trial, with data expected in 2027. If successful, ORKA-001 could redefine the standard of care by offering high-level skin clearance with substantially fewer injections than existing biologics.
Oruka Therapeutics is a biopharmaceutical company developing next-generation biologics for chronic skin and inflammatory diseases. Its lead antibody programs target plaque psoriasis and psoriatic arthritis, aiming to provide complete disease clearance with maintenance dosing as infrequent as once or twice a year.
4. Fastly Inc. (NASDAQ:FSLY)
Year-to-Date Performance: 150.79%
Fastly Inc. (NASDAQ:FSLY) is one of the small-cap stocks that are on fire right now. On April 9, Fastly and LALIGA partnered to develop a joint anti-piracy innovation project aimed at detecting and eliminating illegal live sports streams in real time. This collaboration addresses an economic challenge, as LALIGA estimates that piracy costs its clubs between $700 and $800 million annually. To combat this, Fastly has designed an intelligent detection system that uses AI and proprietary content signals to identify unauthorized broadcasts with high precision, allowing platform customers to remove infringing content quickly.
The partnership focuses on reducing the critical window of opportunity for pirates, which is essential given that recent studies show only a small fraction of illegal retransmissions are currently addressed within the first 30 minutes of an event. Unlike traditional methods like regional blocking, Fastly Inc.’s (NASDAQ:FSLY) solution is built to disable specific pirated segments while ensuring that legitimate traffic remains unaffected.
This initiative is part of a broader strategy by LALIGA, which has already seen a 60% reduction in pirated streams in Spain during the 2024/25 season through legal and technological measures. Fastly and LALIGA are now collaborating with other technology firms, publishers, and regulators to establish industry best practices and software solutions.
Fastly Inc. operates a programmable, high-performance edge cloud platform that delivers faster, safer, and more scalable sites and apps to customers.
3. Veradermics Incorporated (NYSE:MANE)
Year-to-Date Performance: 158.15%
Veradermics Incorporated (NYSE:MANE) is one of the small-cap stocks that are on fire right now. On April 27, Veradermics announced positive topline results from its Phase 2/3 “302” clinical trial evaluating VDPHL01, a proprietary extended-release oral minoxidil formulation for male pattern hair loss. The study, which included 519 participants, met all primary and key secondary endpoints with high statistical significance.
The trial also highlighted strong patient and investigator satisfaction. ~80% to 86% of patients reported improvements in hair coverage. This consistent response across the study population suggests that VDPHL01 could offer a highly reliable and differentiated clinical profile compared to existing off-label or over-the-counter options. Safety data for VDPHL01 was equally encouraging, demonstrating a favorable tolerability profile with adverse event rates similar to those of the placebo.
The extended-release gel matrix is specifically designed to maintain steady absorption while avoiding the high peak concentrations often linked to cardiac side effects. If approved, VDPHL01 would become the first non-hormonal oral treatment for pattern hair loss cleared by the FDA in nearly 30 years, potentially addressing a significant unmet need for the 80 million men and women in the U.S. currently suffering from the condition.
Veradermics Incorporated develops therapies for dermatologic and aesthetic conditions.
2. MaxLinear Inc. (NASDAQ:MXL)
Year-to-Date Performance: 194.55%
MaxLinear Inc. (NASDAQ:MXL) is one of the small-cap stocks that are on fire right now. On April 23, MaxLinear reported Q1 2026 net revenue of $137.2 million, representing a 43% increase year-over-year. This growth was driven by an inflection in the company’s infrastructure business, which surged 136% compared to the prior year. On a non-GAAP basis, the company achieved a gross margin of 59.5% and diluted EPS of $0.22, a notable improvement from the loss of $0.05 per share reported in Q1 2025.
Management attributed this performance to accelerating momentum in optical data center connectivity, particularly for AI-driven hyperscale platforms. Looking ahead, the company provided an optimistic outlook for Q2 2026, projecting net revenue to rise to between $160 and $170 million, marking what management describes as a step-function increase in their optical business.
Additionally, MaxLinear Inc. announced an amendment to its credit agreement with Wells Fargo, extending the maturity of its revolving credit facility to March 2028. The amendment also increased the available facility amount by $30 million, bringing the total capacity to $130 million. While the facility remains undrawn, the extension and increased capacity provide the company with enhanced financial flexibility as it enters what it describes as a multi-year growth phase.
MaxLinear Inc. provides communications systems-on-chip solutions in the US, Asia, Europe, and internationally. It serves electronics distributors, module makers, OEMs, and original design manufacturers.
1. Aehr Test Systems Inc. (NASDAQ:AEHR)
Year-to-Date Performance: 339.20%
Aehr Test Systems Inc. (NASDAQ:AEHR) is one of the small-cap stocks that are on fire right now. On April 16, Aehr Test Systems secured a record $41 million follow-on production order from its primary hyperscale customer, marking the largest single contract in the company’s history. The order is for Aehr’s Sonoma high-power package-level burn-in/PLBI systems, modules, and sockets, which are used to test custom AI processor ASICs for data center training and inference workloads. Deliveries are scheduled to begin in the company’s fiscal year 2027, starting in late June this year.
This latest order brings Aehr’s total bookings for the second half of the fiscal year to over $92 million, significantly exceeding previous management guidance of $60 million to $80 million. CEO Gayn Erickson noted that the Sonoma platform is gaining significant traction as hyperscale providers shift toward custom-designed AI accelerators.
Beyond current production, the lead customer has also placed initial orders for systems to support a next-gen, higher-power AI accelerator expected to enter volume production later this year. To accommodate this surging demand and a growing pipeline across sectors like silicon photonics and power semiconductors (SiC and GaN), Aehr Test Systems Inc. expanded its Fremont, California, facility and upgraded its contract manufacturing capacity.
Aehr Test Systems Inc. designs, markets, manufactures, and sells test and burn-in equipment used in the semiconductor industry. The company’s products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Hedge Fund Resource Center